新闻BenzingaOcugen Executes Licensing Agreement With Roots Pharma And Its Strategic Partner Al-Dhow International For Exclusive Rights To OCU400 For Treatment Of Retinitis Pigmentosa In Middle East And North Africa Region Ocugen Executes Licensing Agreement With Roots Pharma And Its Strategic Partner Al-Dhow International For Exclusive Rights To OCU400 For Treatment Of Retinitis Pigmentosa In Middle East And North Africa Region Benzinga 2026.10.14 10:32 (GMT+0) 在Benzinga上打开 其他新闻 摩根大通维持对 SpaceX 的增持评级，将目标价上调至 500 美元 Keefe, Bruyette & Woods维持对Dime Commercial的“跑赢大盘”评级，将目标价上调至49美元 Keefe, Bruyette & Woods维持对AppFolio的“跑赢大盘”评级，将目标价上调至255美元 BMO资本维持对HealthEquity的“跑赢大盘”评级，将目标价上调至125美元 摩根大通维持对康宁的中性评级，将目标价下调至165美元 BMO资本维持对Equifax的“与大盘一致”评级，将目标价上调至175美元
